Medical and Pharmaceutical Breathe BioMedical adds research site to breast cancer breath test study The Canadian company aims to provide an accurate screening measure for women with dense breast tissue Rowan Dunne11 hours ago
Medical and Pharmaceutical Australian biotech uncovers broader view of tumour genetics with liquid biopsy The team developed the study in collaboration with US sequencing company Illumina Joseph Morton2 days ago
Health & Wellness Quest Diagnostics and University of Texas want to promote more cancer screenings Quest plans to refine, expand, and validate the MCaST technology for its own lab-developed test Joseph MortonJune 11, 2025
Medical and Pharmaceutical Breath Diagnostics opens Respiratory Innovation Summit with captivating presentation It was an honour for the company to be selected to kick off this prestigious event Rowan DunneJune 9, 2025
Medical and Pharmaceutical Dying woman blames CT scan technicians for cancer spread, files lawsuit Their failure to properly interpret the results will cost her life, she claims Rowan DunneJune 6, 2025
Medical and Pharmaceutical Australia’s first national lung cancer screening program begins in July The aim of the game is to save 12,000 lives by 2035 Rowan DunneJune 3, 2025
Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph MortonMay 29, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph MortonMay 26, 2025
Medical and Pharmaceutical Prenetics Global shares spike on significant revenue developments The company projects 2025 revenue to range between USD$73 million and USD$85 million Joseph MortonMay 22, 2025